Serum Peroxiredoxin 4: A Marker of Oxidative Stress Associated with Mortality in Type 2 Diabetes (ZODIAC-28)

• Esther G. Gerrits ,

  * E-mail: esther.gerrits@mumc.nl

  Affiliations Department of Internal Medicine, Maastricht University Medical Center, Maastricht, The Netherlands, Diabetes Centre, Isala Clinics, Zwolle, The Netherlands

  ⨯
• Alaa Alkhalaf,

  Affiliations Diabetes Centre, Isala Clinics, Zwolle, The Netherlands, Department of Gastroenterology, Isala Clinics, Zwolle, The Netherlands

  ⨯
• Gijs W. D. Landman,

  Affiliation Diabetes Centre, Isala Clinics, Zwolle, The Netherlands

  ⨯
• Kornelis J. J. van Hateren,

  Affiliations Diabetes Centre, Isala Clinics, Zwolle, The Netherlands, Langerhans Medical Research Group, Zwolle, The Netherlands

  ⨯
• Klaas H. Groenier,

  Affiliations Diabetes Centre, Isala Clinics, Zwolle, The Netherlands, Department of General Practice, University Medical Center Groningen, Groningen, The Netherlands

  ⨯
• Joachim Struck,

  Affiliation Thermo Fisher Scientific, BRAHMS Biomarkers, Research Department, Hennigsdorf, Germany

  ⨯
• Janin Schulte,

  Affiliation Thermo Fisher Scientific, BRAHMS Biomarkers, Research Department, Hennigsdorf, Germany

  ⨯
• Reinold O. B. Gans,

  Affiliation Department of Internal Medicine, University Medical Center Groningen, Groningen, The Netherlands

  ⨯
• Stephan J. L. Bakker,

  Affiliation Department of Internal Medicine, University Medical Center Groningen, Groningen, The Netherlands

  ⨯
• Nanne Kleefstra,

  Affiliations Diabetes Centre, Isala Clinics, Zwolle, The Netherlands, Langerhans Medical Research Group, Zwolle, The Netherlands, Department of Internal Medicine, University Medical Center Groningen, Groningen, The Netherlands

  ⨯
• Henk J. G. Bilo

  Affiliations Diabetes Centre, Isala Clinics, Zwolle, The Netherlands, Department of Internal Medicine, University Medical Center Groningen, Groningen, The Netherlands, Department of Internal Medicine, Isala Clinics, Zwolle, The Netherlands

  ⨯